| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 26,820,000 | 24,502,000 | 28,866,000 | 24,119,000 | | Cost of Revenue | 15,220,000 | 14,336,000 | 15,897,000 | 14,163,000 | | | Gross Profit | 11,600,000 | 10,166,000 | 12,969,000 | 9,956,000 | | | Operating Expenses | | Research Development | 1,661,000 | 1,569,000 | 1,585,000 | 1,524,000 | | Selling General and Administrative | 6,082,000 | 5,620,000 | 6,016,000 | 5,325,000 | | Non Recurring | (285,000) | (274,000) |
-
| 451,000 | | Others | 207,000 |
-
|
-
|
-
| | | | Total Operating Expenses | 7,665,000 |
-
|
-
|
-
| | | | Operating Income or Loss | 3,935,000 | 3,251,000 | 5,368,000 | 2,656,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 24,000 | 125,000 | 335,000 | 817,000 | | Earnings Before Interest And Taxes | 3,959,000 | 3,376,000 | 5,703,000 | 3,473,000 | | Interest Expense | 145,000 | 178,000 | 215,000 | 193,000 | | Income Before Tax | 3,814,000 | 3,198,000 | 5,488,000 | 3,280,000 | | Income Tax Expense | 1,049,000 | 879,000 | 1,537,000 | 918,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,765,000 | 2,319,000 | 3,951,000 | 2,362,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 1,000 | (1,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,765,000 | 2,319,000 | 3,952,000 | 2,361,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,765,000 | $2,319,000 | $3,952,000 | $2,361,000 |
|
0.12% Nasdaq 
2.34%
Income Statement
